Compare ARK Genomic Revolution ETF (ARKG) vs Bilibili Inc (BILI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Bilibili Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.55, while Bilibili Inc trades at $17.55 (market cap $7.43B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Bilibili Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BILI | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $35.92 |
52-Week Low | $23.09 | $15.96 |
Market Cap | — | $7.43B |
Enterprise Value | — | $5.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Bilibili (BILI) trades at $17.7, down 0.78% on the day. The stock shows neutral technical signals with mixed moving averages and oscillators. Fundamentally, the company reported Q1 2026 earnings of $0.19 per share, beating estimates, with revenue growth driven by advertising and value-added services. A new $300 million share repurchase program announced in June 2026 signals management confidence.
The outlook is cautiously optimistic, supported by strong analyst buy ratings (83%) and recent earnings beats. Key opportunities include margin expansion and user growth, while risks involve competitive pressures and reliance on the Chinese consumer market. The stock presents a growth opportunity with manageable risks for investors seeking exposure to China's digital content sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Bilibili Inc
Bilibili is a leading video sharing and online entertainment platform for Gen Z in China. It offers a diverse range of content, including anime, games, and live broadcasting, fueled by a highly engaged community.
Read more on BILI →
